A startup hoping to redefine “all-in-one glucose meter” is looking for a $3 million boost for its one-click diabetes testing device that combines a lancing device with nanotechnology sensors that measure blood glucose.

Pepex Biomedical Inc.’s blood glucose meter, the Trio, combines all of the diabetes testing materials in one device and replaces test strips with disposable, miniaturized enzymatic-based biosensors. The advantage, according to the company, is that it requires no handling of sharps and reduces environmental and user-induced error by eliminating test strips. The device doesn’t actually draw blood, according to CFO Joseph Driver. Rather, it tests the blood at the tissue source.

Click here to read the full story